Willingness to initiate pre-exposure prophylaxis (PrEP) and its use among opioid-dependent individuals in drug treatment
- PMID: 33422864
- PMCID: PMC7946167
- DOI: 10.1016/j.drugalcdep.2020.108477
Willingness to initiate pre-exposure prophylaxis (PrEP) and its use among opioid-dependent individuals in drug treatment
Abstract
Background: People who use drugs (PWUD) continue to experience a disproportionate HIV burden due to drug- and sex-related risk behaviors. Pre-exposure prophylaxis (PrEP) is highly effective at preventing HIV infection, but very little is known about PrEP use among PWUD and their willingness to initiate PrEP.
Methods: We conducted a cross-sectional survey among 234 HIV-negative, opioid-dependent individuals recruited from an urban methadone clinic. Participants were assessed using an audio-computer assisted self-interview technique. Bivariate and multiple logistic regressions were used to explore independent correlates of actual PrEP use and willingness to initiate PrEP.
Results: One-fourth (25.6 %) of participants had previously used PrEP. Over two-thirds (67.1 %) of participants had previously heard of PrEP, and 65.0 % were willing to take it. In multivariable logistic regression analyses, the number of times participants engaged in HIV testing (aOR = 1.66, p < 0.01) and whether they visited a healthcare provider (aOR=20.81, p = 0.02) were associated with a higher likelihood of PrEP use, while perceived HIV risk (aOR=2.71, p < 0.01) and previous use of PrEP (aOR=3.57, p < 0.01) were significantly associated with willingness to initiate PrEP.
Conclusion: PrEP use was low among PWUD, but their willingness to initiate PrEP was moderate, which indicated a significant discrepancy between actual PrEP use and willingness to use it. Our findings highlight the importance of healthcare providers engaging opioid-dependent individuals in discussions about PrEP and the need for innovative strategies to increase their awareness of PrEP and modify their perceptions of HIV risk.
Keywords: HIV prevention; Opioid use disorder; Opioid-dependent; People who use drugs (PWUD); Pre-exposure prophylaxis (PrEP); Sexual risk behavior; Substance use.
Copyright © 2020 Elsevier B.V. All rights reserved.
Conflict of interest statement
Figures
Similar articles
-
Correlates of willingness to initiate pre-exposure prophylaxis and anticipation of practicing safer drug- and sex-related behaviors among high-risk drug users on methadone treatment.Drug Alcohol Depend. 2017 Apr 1;173:107-116. doi: 10.1016/j.drugalcdep.2016.12.023. Epub 2017 Feb 2. Drug Alcohol Depend. 2017. PMID: 28214391 Free PMC article.
-
Awareness about and willingness to use long-acting injectable pre-exposure prophylaxis (LAI-PrEP) among people who use drugs.J Subst Abuse Treat. 2020 Oct;117:108058. doi: 10.1016/j.jsat.2020.108058. Epub 2020 Jun 15. J Subst Abuse Treat. 2020. PMID: 32811633 Free PMC article.
-
Willingness to use pre-exposure prophylaxis for HIV prevention among men who have sex with men in Malaysia: Findings from an online survey.PLoS One. 2017 Sep 13;12(9):e0182838. doi: 10.1371/journal.pone.0182838. eCollection 2017. PLoS One. 2017. PMID: 28902857 Free PMC article.
-
Pre-exposure prophylaxis (PrEP) indication and uptake among people receiving buprenorphine for the treatment of opioid use disorder.J Subst Abuse Treat. 2022 Jan;132:108506. doi: 10.1016/j.jsat.2021.108506. Epub 2021 May 31. J Subst Abuse Treat. 2022. PMID: 34098202 Free PMC article. Review.
-
The Past, Present, and Future of PrEP implementation Among People Who Use Drugs.Curr HIV/AIDS Rep. 2021 Aug;18(4):328-338. doi: 10.1007/s11904-021-00556-z. Epub 2021 Apr 27. Curr HIV/AIDS Rep. 2021. PMID: 33907971 Free PMC article. Review.
Cited by
-
Fentanyl Test Strip Use and Overdose History among Individuals on Medication for Opioid Use Disorder.Austin J Public Health Epidemiol. 2021;8(5):1117. Epub 2021 Dec 29. Austin J Public Health Epidemiol. 2021. PMID: 35782633 Free PMC article.
-
Associations of HIV pre-exposure prophylaxis (PrEP) indication, HIV risk perception and unwillingness to use PrEP among people who inject drugs in Baltimore, MD.Drug Alcohol Depend Rep. 2024 Oct 8;13:100288. doi: 10.1016/j.dadr.2024.100288. eCollection 2024 Dec. Drug Alcohol Depend Rep. 2024. PMID: 39498373 Free PMC article.
-
Race, trust, and COVID-19 vaccine hesitancy in people with opioid use disorder.Health Psychol. 2022 Feb;41(2):115-120. doi: 10.1037/hea0001120. Epub 2021 Dec 2. Health Psychol. 2022. PMID: 34855415 Free PMC article.
-
Readiness to implement contingency management to promote PrEP initiation and adherence among people who inject drugs: results from a multi-site implementation survey.Addict Sci Clin Pract. 2024 Dec 23;19(1):97. doi: 10.1186/s13722-024-00503-4. Addict Sci Clin Pract. 2024. PMID: 39710733 Free PMC article.
-
Logistical Facilitators and Barriers to PrEP Implementation in Methadone Clinic Settings: Provider and Staff Perspectives.J Addict Med. 2022 Sep-Oct 01;16(5):e278-e283. doi: 10.1097/ADM.0000000000000973. Epub 2022 Feb 14. J Addict Med. 2022. PMID: 35165229 Free PMC article.
References
-
- Centers for Disease Control and Prevention (CDC). HIV and People Who Inject Drugs, https://www.cdc.gov/hiv/group/hiv-idu.html. Published 2020. Updated February 6, 2020. Accessed June 19, 2020.
-
- Ungar Laura. 5 Years After Indiana's Historic HIV Outbreak, Many Rural Places Remain At Risk. https://www.npr.org/sections/health-shots/2020/02/16/801720966/5-years-a.... Published 2020. Accessed February 23, 2020.
-
- Varney Sarah. Rural Indiana Struggles With Drug-Fueled HIV Epidemic. Kasier Health News. https://khn.org/news/rural-indiana-struggles-with-drug-fueled-hiv-epidemic/. Published 2015. Accessed February 23, 2020.
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous